Skip to content
BIO aids global harmonization, helping speed cures to patients
The process of holding clinical trials and gaining FDA approval takes up much ...
Read More
More parents oppose routine childhood vaccines since 2019, survey shows
One-third of parents now oppose public schools requiring students to get routine childhood ...
Read More
BIO hosts industry and government leaders in Africa Summit side event targeting cancer
The Biotechnology Innovation Organization (BIO) hosted leaders from industry and governments in the ...
Read More
FDA cuts back on Accelerated Approval pathway in 2022
The Accelerated Approval (AA) pathway, one of the U.S. Food and Drug Administration’s ...
Read More
Common bacterial infections behind every eight death in the world in 2019, study says
One in eight global deaths in 2019 was caused by common bacterial infections, ...
Read More
2022 midterms recap: what happened and what the results mean for biotech
The 2022 midterms are officially behind us – so, what happened, and what ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
Bioeconomy
Bayh-Dole at 45: Still an engine for innovation
A researcher working in a university lab makes a discovery that could lead to a new cure. Investors who see the potential of the discovery ...
BIO's View
House passes BIO-backed legislation to increase access to capital
Legislation to free up capital for small innovative firms by removing regulatory barriers for both companies and investors passed the House Dec. 11—a move praised ...
BIO's View
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another transformative sector: health care innovation. ...
Health
BIO-CSBA report explains why and how states seek to attract biotech
While U.S. biotech leadership is recognized as essential for national security, states also understand the industry’s local benefits and are implementing policies designed to attract ...
Federal Policy
Breaking barriers to a cure: Patient perspectives matter in type 1 diabetes innovation
When it comes to enabling new treatments for type 1 diabetes (T1D), Breakthrough T1D is an outstanding example of a patient group driving research and ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Charlotte emerging as a global leader in health care innovation and med tech
Historically, Charlotte has been recognized as a major U.S. financial hub. Now, the city is making significant strides in another ...
Read More
International
Bio's View
House passes BIO-backed legislation to increase access to capital
Legislation to free up capital for small innovative firms by removing regulatory barriers for both companies and investors passed the ...
Read More
